title: The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy.
abstract: Hormone replacement therapy for postmenopausal women greatly reduces their risk of coronary heart disease. However, current pharmaceutical regimens have a low acceptance rate among postmenopausal women. We have sought to identify an alternative treatment that would retain the beneficial health effects of current standard therapy without its negative aspects. We have concentrated our research on naturally occurring estrogens (called phytoestrogens) found in soybeans, in the belief that delivery of phytoestrogens via the diet would be more acceptable than pharmaceutical regimens. Using a well-established nonhuman primate model of postmenopausal women, we have investigated the effects of soy phytoestrogens on cardiovascular risk factors and the reproductive system. In this review, we summarize the results of our ongoing research.
authors.affiliation: Comparative Medicine Clinical Research Center, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina 27157-1040, USA. tclarkson@cpm.bgsm.edu
authors.forename: T B
authors.initials: TB
authors.lastname: Clarkson
authors.forename: M S
authors.initials: MS
authors.lastname: Anthony
authors.forename: J K
authors.initials: JK
authors.lastname: Williams
authors.forename: E K
authors.initials: EK
authors.lastname: Honoré
authors.forename: J M
authors.initials: JM
authors.lastname: Cline
mesh_terms: D000818:Animals; D015914:Estrogen Replacement Therapy; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007529:Isoflavones; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D009929:Organ Size / Q000187:drug effects; D048789:Phytoestrogens; D028321:Plant Preparations; D017698:Postmenopause; D013025:Glycine max
chemical_list: D004968:Estrogens, Non-Steroidal; D007529:Isoflavones; D008055:Lipids; D008074:Lipoproteins; D048789:Phytoestrogens; D028321:Plant Preparations